Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Phase I metabolism" does not refer to a specific molecule, receptor, enzyme, or drug target; rather, it denotes a class of metabolic biochemical reactions—primarily oxidation, reduction, and hydrolysis—that are responsible for modifying xenobiotics (such as drugs) in the body[1][2][3][4][5][6][8]. The central function of Phase I metabolism is to introduce or unmask functional groups (e.g., hydroxyl, amino, carboxyl), increasing the polarity of the compound and preparing it for further metabolism or excretion[2][3][5][8]. The major enzymes involved in Phase I metabolism are predominately members of the cytochrome P450 (CYP450) enzyme superfamily[2][3][4][5]. However, referring to "Phase I metabolism" as a single, concrete target is incorrect; it is a process involving multiple enzyme systems, particularly but not exclusively CYP450s[4][5]. Phase I metabolism does not itself act as a direct therapeutic target, nor is it a molecule or receptor to which drugs directly bind; rather, it is a collection of reaction pathways that modifies drugs and other xenobiotics in the body[4][5][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phase I metabolism.